Skip to main content Accessibility help
×
Home

Efficiency of Human Immunodeficiency Virus Transmission Through Injections and Other Medical Procedures Evidence, Estimates, and Unfinished Business

  • David Gisselquist (a1), Garance Upham (a2) and John J. Potterat (a3)

Abstract

Objective.

To estimate the transmission efficiency of human immunodeficiency virus (HIV) through medical injections and other invasive procedures.

Design.

We searched our own files and Medline (from 1966-2004, using the keywords [“iatrogenic” or “nosocomial” or “injections”] and “HIV”) for reports of iatrogenic outbreaks worldwide, except outbreaks traced to receipt of contaminated blood or blood products. We also analyzed information from a case-control study of percutaneous exposures to healthcare workers.

Setting.

Worldwide healthcare settings.

Events.

We identified 8 iatrogenic outbreaks that met our study criteria; published information from 4 outbreaks was sufficient to estimate transmission efficiency.

Results.

From the 4 documented iatrogenic outbreaks, we estimated that 1 iatrogenic infection occurred after 8-52 procedures involving HIV-infected persons. Although only 0.3% of healthcare workers seroconvert after percutaneous exposure, a case-control study reported that deep injuries and other risk factors collectively increased seroconversion risk by as much as 50 times. Laboratory investigations demonstrate HIV survival through time and various rinsing regimens. We estimate that the transmission efficiency in medical settings with no or grossly insufficient efforts to clean equipment ranges from 0.5% to 3% for lower risk procedures (eg, intramuscular injections) and from 10% to 20% or more for high-risk procedures. Efforts to clean equipment, short of sterilization, may cut the transmission efficiency by 0%-100%. Procedures that contaminate multidose vials may accelerate transmission efficiency.

Conclusion.

To achieve better estimates of the transmission efficiency for a range of medical procedures and settings, investigations of iatrogenic outbreaks should be accorded high priority.

Copyright

Corresponding author

29 West Governor Road, Hershey, PA 17033, (david_gisselquist@yahoo.com)

References

Hide All
1.Allard, R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Syndr 1990; 3: 1010-1016.
2.Heymann, DL, Edstrom, K. Strategies for AIDS prevention and control in sub-Saharan Africa. AIDS 1991; 5(Suppl 1):S197S208.
3.Hoelscher, M, Riedner, G, Hemed, Y, Wagner, H-U, Korte, R, von Sonnenburg, F. Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania. AIDS 1994; 8:16091615.
4.Aylward, B, Kane, M, McNair-Scott, R, Hu, DH. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections. Int J Epidemiol 1995; 24:446452.
5.Kane, A, Lloyd, J, Zaffran, M, Simonsen, L, Kane, M. Transmission of hepatitis B, hepatitis C, and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull WHO 1999; 77:801807.
6.Ekwueme, DU, Weniger, GB, Chen, RT. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa. Bull WHO 2002; 80:859870.
7.Hauri, AJ, Armstrong, GL, Hutin, YJF. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15:716.
8.Schmid, GP, Buve, A, Mugyenyi, P, et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004; 363:482488.
9.Kaplan, EH, Heimer, R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992; 5:11161118.
10.Hudgens, MG, Longini, IM Jr, Halloran, ME, et al. Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand. Appl Statist 2001; 50:114.
11.Hudgens, MG, Longini, IM Jr, Vanichsensi, S, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 2002; 155:159168.
12.Baggaley, RF, Boily, M-C, White, RG, Alary, M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 2006; 20:805812.
13.Porco, TC, Aragon, TJ, Fernyak, SE, et al. Quantitative Risk Assessment for Needle Reuse at a Phlebotomy Center: Parameter Estimation, Scenario Evaluation, Sensitivity Analysis. May 22, 2000. San Francisco: San Francisco Department of Public Health. Available at: http://www.dph.sf.ca.us/Reports/ndlreuse.pdf. Accessed August 1, 2006.
14.Avila, C, Stetler, HC, Sepúlveda, J, et al. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico. AIDS 1989; 3:631633.
15.Banerjee, K, Rodrigues, J, Israel, Z, Kulkarni, S, Thakar, M. Outbreak of HIV seropositivity among commercial plasma donors in Pune, India [letter]. Lancet 1989; 2:166.
16.Pokrovski, W, Eramova, IIU, Deulina, MO, et al. An intrahospital outbreak of HIV infection in Elista [in Russian]. Z Microbiol Epidemiol Immunobiol 1990; 4:1723.
17.Pokrovsky, VV. Localization of nosocomial outbreak of HIV infection in southern Russia in 1988-89. In: Proceedings of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, The Netherlands. Abstract PoC 4138.
18.Bobkov, A, Garaev, MM, Rzhaninova, A, et al. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data. AIDS 1994; 8:619624.
19.Sauhat, SR, Kotova, EA, Prokopenkova, SA, et al. Risk factors for HIV transmission in hospital outbreak [abstract]. In: Proceedings of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, The Netherlands. Abstract PoC 4288.
20.Hersh, BS, Popovici, F, Jezek, Z, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS 1993; 7:16171624.
21.Patrascu, IV, Dumitrescu, O. The epidemic of human immunodeficiency virus infection in Romanian children. AIDS Res Hum Retroviruses 1993; 9:99104.
22.Hassan, NF, El Ghorab, NM, Rehim, MS, et al. HIV infection in renal dialysis patients in Egypt [letter]. AIDS 1994; 8:853.
23.Pugliese, G. HIV transmission reported in dialysis center. Infect Cont Hosp Epidemiol 1995; 16:482.
24.Wu, Z, Rou, K, Detels, R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan 2001; 16:4146.
25.Zhang, K, Gui, X, Su, B, Chen, Z, Zhang, L. High prevalence of HIV infection among women and their children in Henan Province, China [letter]. J Acquir Immune Defic Syndr 2003; 33:649650.
26.Ministry of Health, People's Republic of China. 2005 Update on the HIV/AIDS Epidemic and Response in China. Geneva: UNAIDS; 2006.
27.Su, B, Liu, L, Wang, F, et al. HIV-1 subtype B dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003; 17:25152520.
28.Beach, MV. “Blood heads” and AIDS haunt China's countryside. Lancet 2001; 357:49.
29.Shan, H, Wang, J-X, Ren, F-R, et al. Blood banking in China. Lancet 2002; 360:17701775.
30.Visco-Comandini, U, Cappiello, G, Luizzi, G, et al. Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya. AIDS Res Hum Retroviruses 2002; 18:727732.
31.Quadri, R, Yerli, S, Posfay-Barbe, K, et al. Outbreak of blood-borne viral infections in children attending a single hospital [abstract]. Hepatology 2000; 32:281A.
32.Yerly, S, Quadri, R, Negro, F, et al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis 2001; 184:369372.
33.Shields, J. Patient-to-patient transmission of HIV [letter]. Lancet 1994; 343:415.
34.Gisselquist, D. Estimating HIV-1 transmission efficiency through unsafe medical injections. Int J STD AIDS 2002; 13:152159.
35.Bell, DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102(Suppl 5B):915.
36.Gerberding, JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure; final report from a longitudinal study. J Infect Dis 1994; 170:14101417.
37.Tokars, JI, Marcus, R, Culver, DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposures to HIV-infected blood. Ann Intern Med 1993; 118:913919.
38.Kaplan, EH. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis 1989; 11:289298.
39.Van de Perre, P, Diakhate, L, Watson-Williams, J. Prevention of blood-borne transmission of HIV. AIDS 1997; 11(Suppl B):S89S98.
40.Cardo, DM, Culver, DH, Ciesielski, CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997; 337:14851490.
41.Goletti, D, Weissman, D, Jackson, RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996; 157:12711278.
42.Gray, RH, Wawer, MJ, Brookmeyer, R, et al. Probability of HIV-1 transmission per coital act in monogamous heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet 2001;357:11491153.
43.Piatak, M, Saag, MS, Yang, LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259:17491754.
44.Richardson, BA, Mbori-Ngacha, D, Lavreys, L, et al. Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. J Virol 2003; 77:71207123.
45.Gisselquist, D, Potterat, JJ, Brody, S. HIV transmission during paediatric health care in sub-Saharan Africa: risks and evidence. S Afr Med J 2004; 94:109116.
46.Heimer, R, Abdala, N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. AIDS Reader 2000; 10:410417.
47.Grund, J-PC, Stern, LS. Residual blood in syringes: size and type of syringe are important. AIDS 1991; 5:15321533.
48.Hughes, RR. Post-penicillin jaundice. BMJ 1946; 2:685688.
49.Rich, JD, Dickinson, BP, Carney, JM, Fisher, A, Heimer, R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998; 12:23452350.
50.Kanitakis, J, Escaich, S, Trepo, C, Thivolet, J. Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol 1991; 97:9196.
51.Blauvelt, A. The role of skin dendritic cells in the initiation of human immunodeficiency virus infection. Am J Med 1997; 102(Suppl 5B):1620.
52.Soto-Ramirez, LE, Renjifo, B, McLane, MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:12911293.
53.Essex, M, Renjifo, B, Peña-Cruz, V, et al. Different subtypes of HIV-1 and cutaneous dendritic cells: response [letter]. Science 1997; 278:787788.
54.Evans, RJ, Spooner, ETC. A possible mode of transfer of infection by syringes used for mass inoculation. BMJ 1950; 2:185188.
55.Hutin, Y, Hauri, A, Chiarello, L, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull WHO 2003; 81:491500.
56.Resnick, L, Veren, K, Salahuddin, SZ, Tondreau, S, Markham, PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986; 255:18871891.
57.Lakshman, M, Nichter, M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study. Soc Sci Med 2000; 51:1128.
58.Birungi, H, Asiimwe, D, Whyte, SR. Injection Use and Practices in Uganda (WHO/DAP/94.18). Geneva, Switzerland: World Health Organization; 1994.
59.Druce, JD, Locarnini, SA, Birch, CJ. Syringe cleaning techniques and transmission of HIV [letter]. AIDS 1995; 9:11051107.
60.Abdala, N, Cleghorn, AA, Carney, JM, Heimer, J. Can HIV-1-contaminated syringes be disinfected. J Acquir Immune Defic Syndr 2001; 28:487494.
61.Van Bueren, J, Simpson, RA, Salman, H, Farrelly, HD, Cookson, BD. Inactivation of HIV-1 by chemical disinfectants: sodium hypochlorite. Epidemiol Infect 1995; 115:567579.
62.Contoreggi, C, Jones, S, Simpson, P, Lange, WR, Meyer, WA III. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use. Intervirology 2000; 43:15.
63.Lakshmi, R. India's vaccines come with risk: dirty needles used for immunization can spread other diseases. Washington Post February 9,2005:A18.
64.Hu, DJ, Kane, MA, Heymann, DL. Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health settings: a review of risk factors and guidelines for prevention. Bull WHO 1991; 69:623630.

Efficiency of Human Immunodeficiency Virus Transmission Through Injections and Other Medical Procedures Evidence, Estimates, and Unfinished Business

  • David Gisselquist (a1), Garance Upham (a2) and John J. Potterat (a3)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed